This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Business / Innate Pharma to Present at AACR
Business presentation

Innate Pharma to Present at AACR

Analysis based on 6 articles · First reported Apr 08, 2026 · Last updated Apr 08, 2026

Sentiment
10
Attention
2
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The presentation by Innate Pharma at the American Association for Cancer Research event could positively impact Innate Pharma's stock price by attracting new investors and potentially leading to new collaborations. This event provides a platform for Innate Pharma to highlight its oncology pipeline, which could accelerate the development of its therapies.

biotechnology pharmaceuticals
Event Summary

Innate Pharma announced that its Chief Operating Officer, Yannis Morel, will present at the American Association for Cancer Research Oncology Industry Partnering Event on April 16, 2026, in San Diego, California. This event is a forum for venture capitalists, investment bankers, biotech, and pharmaceutical leaders to discuss oncology drug development. Innate Pharma's selection to present is seen as a recognition of its clinical pipeline, including IPH4502, lacutamab, and monalizumab (developed with AstraZeneca). The company aims to share progress on its key assets and foster interactions that could accelerate the development of its differentiated therapies for cancer patients. Sanofi is also mentioned as a collaborator.

Entities Involved
stock
Innate Pharma
Innate Pharma will present its oncology pipeline and strategies at the AACR Oncology Industry Partnering Event, providing an opportunity to attract investors and accelerate therapy development.
Importance 100.0 Sentiment 20.0
per
Yannis Morel
Yannis Morel, Chief Operating Officer of Innate Pharma, will be the presenter at the AACR Oncology Industry Partnering Event, representing Innate Pharma's interests.
Importance 70.0 Sentiment 0.0
ngo
American Association for Cancer Research
The American Association for Cancer Research is hosting the AACR Oncology Industry Partnering Event, providing a platform for biotechnology companies like Innate Pharma to showcase their innovations.
Importance 60.0 Sentiment 0.0
stock
AstraZeneca
AstraZeneca is mentioned as a collaborator with Innate Pharma, specifically on the monalizumab antibody for non-small cell lung cancer.
Importance 10.0 Sentiment 0.0
stock
Sanofi
Sanofi is mentioned as a collaborator with Innate Pharma, indicating existing partnerships in immuno-oncology.
Importance 10.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.